Mobile Gamma Cameras Market
By Product Type;
Single-Head Mobile Gamma Cameras, Dual-Head Mobile Gamma Cameras, Triple-Head Mobile Gamma Cameras and Handheld Mobile Gamma CameraBy Application;
Cardiac Imaging, Breast Imaging, Thyroid Scanning, Kidney Scanning, Intraoperative Imaging and OthersBy End-User;
Hospital, Imaging Centers & Clinics and Research CentersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Mobile Gamma Cameras Market Overview
Mobile Gamma Cameras Market (USD Million)
Mobile Gamma Cameras Market was valued at USD 64.69 million in the year 2024. The size of this market is expected to increase to USD 89.22 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.7%.
Mobile Gamma Cameras Market
*Market size in USD million
CAGR 4.7 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 4.7 % |
| Market Size (2024) | USD 64.69 Million |
| Market Size (2031) | USD 89.22 Million |
| Market Concentration | High |
| Report Pages | 325 |
Major Players
- Beijing Hamamatsu Photon Techniques INC.
- DDD-Diagnostic A/S
- Digirad Corporation
- Dilon Technologies
- GAEDE Medizinsysteme GmbH
- Gammasonics Pty
- GE Healthcare
- Mediso Ltd
- MEDX
- Philips
- Siemens Healthcare
- Spectrum Dynamics Medical
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Mobile Gamma Cameras Market
Fragmented - Highly competitive market without dominant players
The Mobile Gamma Cameras Market is witnessing robust growth driven by the need for portable diagnostic solutions in nuclear medicine. These mobile devices offer enhanced flexibility in imaging procedures, especially in critical care and remote settings. With over 45% of healthcare facilities incorporating portable imaging systems, the shift toward mobile modalities is accelerating due to reduced operational constraints and improved patient convenience.
Rising Demand in Emergency and Bedside Imaging
The increased preference for bedside nuclear imaging is a major factor fueling the market expansion. Nearly 40% of hospitals report higher usage of mobile gamma cameras in intensive care units and emergency departments. These compact systems reduce patient movement and enable immediate diagnostics, particularly for vulnerable or immobile patients, improving outcomes and workflow efficiency.
Technological Advancements Enhancing Performance
Continuous innovation in detector design and software integration has significantly improved the resolution and diagnostic accuracy of mobile gamma cameras. Around 35% of mobile devices now feature solid-state detectors and AI-enhanced image reconstruction, allowing for faster imaging with lower radiation doses. These innovations are critical for broader clinical adoption and physician confidence.
Growing Use in Oncology and Cardiology
Mobile gamma cameras are increasingly used in oncology and cardiology diagnostics due to their high sensitivity in detecting abnormal tissue and cardiac function. Over 50% of nuclear medicine departments utilize mobile units in cancer staging and myocardial perfusion imaging. Their deployment in outpatient and ambulatory care settings enhances diagnostic reach and reduces patient backlogs.
Mobile Gamma Cameras Market Key Takeaways
-
Rising prevalence of chronic diseases such as cancer and cardiac disorders is increasing the demand for gamma cameras in nuclear medicine imaging and diagnostics.
-
Technological advancements enhance imaging precision: The integration of digital detectors, solid-state sensors, and hybrid SPECT/CT systems improves spatial resolution and diagnostic accuracy.
-
Growing use in oncology and cardiology as gamma cameras play a critical role in monitoring tumor progression and evaluating myocardial perfusion, supporting personalized treatment planning.
-
Portable and compact systems gain traction due to their cost-effectiveness and accessibility in smaller healthcare facilities and outpatient diagnostic centers.
-
Increased adoption of dual-head and triple-head designs enables faster image acquisition and higher throughput in clinical workflows.
-
Regulatory approvals and safety standards drive product innovation and market confidence, with manufacturers focusing on low-dose and high-efficiency imaging technologies.
-
Strategic collaborations and R&D investment among key market players are accelerating the development of next-generation gamma cameras with enhanced sensitivity and integration capabilities.
Mobile Gamma Cameras Market Recent Developments
-
In January 2023 the Mobile Gamma Cameras Market witnessed the launch of a new ultra-compact mobile gamma camera designed for bedside and remote-clinic use, enhancing portability and access to functional imaging.
-
In September 2025 the Mobile Gamma Cameras Market saw increased deployment of next-generation mobile gamma camera systems with integrated AI-enabled image reconstruction and extended detector sensitivity, expanding applications in oncology and cardiology.
Mobile Gamma Cameras Market Segment Analysis
In this report, the Mobile Gamma Cameras Market has been segmented by Product Type, Application, End-User and Geography.
Mobile Gamma Cameras Market, Segmentation by Product Type
The product mix defines positioning, clinical workflows, and procurement strategies for mobile nuclear imaging. Vendors differentiate through detector configuration, portability profiles, and integration with hospital IT, influencing deployment across acute, ambulatory, and intraoperative settings. Buyers weigh throughput, image quality, footprint, and total cost of ownership, with upgrades centered on solid-state detectors, low-dose protocols, and rapid setup to expand point-of-care imaging.
Single-Head Mobile Gamma Cameras
Single-head systems emphasize maneuverability and simpler setup for bedside and small-room use. They serve facilities prioritizing portability, ease of disinfection, and fast turnaround, particularly in wards where patient transport is constrained. Typical use cases include focused studies where workflow efficiency outweighs multiprojection speed, with procurement favored by lower capital outlay and flexible service contracts.
Dual-Head Mobile Gamma Cameras
Dual-head configurations balance image quality with higher throughput, enabling improved count sensitivity and multi-angle acquisitions without significantly compromising mobility. They align with departments standardizing on versatile platforms for cardiac, breast, thyroid, and musculoskeletal scans at the point of care. Purchasing decisions often reflect the need for exam standardization across sites and smoother scheduling between inpatient and outpatient flows.
Triple-Head Mobile Gamma Cameras
Triple-head systems target advanced protocols where resolution and sensitivity are critical, supporting complex tomographic workflows in constrained spaces. While heavier and costlier, they can reduce study times and enhance diagnostic confidence for specialized indications, appealing to tertiary centers and academic hubs. Adoption is driven by clinical differentiation and research capabilities that justify premium budgets.
Handheld Mobile Gamma Camera
Handheld devices focus on ultra-portable, intraoperative, and bedside localization, extending nuclear imaging into theater suites and clinics. Surgeons and interventional teams value quick start-up, real-time guidance, and minimal footprint for sentinel node mapping and lesion localization. Growth is supported by training programs, procedure standardization, and compatibility with sterile workflows and draping systems.
Mobile Gamma Cameras Market, Segmentation by Application
Clinical applications determine protocol design, reimbursement, and device selection across diagnostic and intraoperative pathways. Providers evaluate modality fit, dose management, and care-pathway impact when moving studies to the bedside or OR. Expansion into perioperative oncology and critical-care settings underscores the value of rapid access, reducing patient transfers while safeguarding image quality for confident decision-making.
Cardiac Imaging
Bedside cardiac protocols benefit from decreased patient movement and faster triage for suspected ischemia or perfusion anomalies. Mobile systems support stress and rest workflows in units where transport poses risks, aligning with value-based care goals. Adoption correlates with reliable attenuation handling and integration into cardiology information systems for streamlined reporting.
Breast Imaging
Molecular breast imaging with mobile platforms can complement mammography and ultrasound in dense breast evaluation and treatment planning. Hospitals leverage flexible rooming and on-demand scheduling to reduce bottlenecks, especially during equipment downtime or renovations. Emphasis rests on dose optimization, lesion detectability, and clear referral pathways to ensure appropriate utilization.
Thyroid Scanning
Thyroid studies are well suited to compact systems that streamline uptake measurements and targeted imaging in endocrine clinics. Mobility supports satellite clinics and outreach programs while preserving protocol consistency for longitudinal follow-up. Growth is tied to standardized QA procedures and technician training that maintain accuracy across locations.
Kidney Scanning
Renal function and drainage assessments benefit from proximity to nephrology wards and pediatric units, reducing transfer delays. Mobile platforms enable flexible scheduling for dynamic studies and diuretic protocols while maintaining patient comfort. Procurement teams value dose-tracking, time-activity analysis, and interoperability with PACS for rapid consultation.
Intraoperative Imaging
Intraoperative use prioritizes real-time localization for sentinel node mapping, parathyroid detection, and targeted oncology procedures. Systems must integrate with OR sterility, draping, and surgeon ergonomics, delivering intuitive interfaces for quick decision cycles. Hospital programs scale utilization by embedding protocol checklists, training, and device availability within block schedules.
Others
This category spans emerging and niche procedures where portability expands access, including musculoskeletal, infection, and neuro applications. Pilots often precede broader rollout, with outcomes tracked for cost-effectiveness and patient throughput. Growth depends on clinical evidence, pathway integration, and cross-department collaboration.
Mobile Gamma Cameras Market, Segmentation by End-User
End-user profiles shape capital planning, staffing, and service models for mobile nuclear imaging. Hospitals, imaging centers & clinics, and research institutions differ in protocol scope, uptime requirements, and innovation priorities. Vendors tailor offerings—ranging from handheld to multi-head carts—alongside training, service, and financing to fit site-level objectives.
Hospital
Hospitals prioritize bedside access for critical and immobile patients, reducing transport risk and accelerating care. Multi-department utilization across cardiology, oncology, endocrine, and surgery supports strong ROI through higher asset use. Decision criteria emphasize infection control, uptime SLAs, and integration with enterprise imaging.
Imaging Centers & Clinics
Ambulatory sites focus on throughput, scheduling efficiency, and patient experience in compact spaces. Mobile units help bridge gaps during room refurbishments or modality upgrades while maintaining service continuity. Competitive differentiation stems from fast reporting, flexible protocols, and referral partnerships.
Research Centers
Research users value platforms that support protocol development, device trials, and investigator-initiated studies. Flexibility for experimental collimators, tracers, and acquisition schemes encourages translational work. Collaboration with surgeons and nuclear medicine teams advances evidence and showcases novel use cases.
Mobile Gamma Cameras Market, Segmentation by Geography
Geographic dynamics reflect variations in procedure volumes, reimbursement, infrastructure, and workforce. Mature markets emphasize replacement cycles, dose-reduction technology, and standardization, while growth regions expand access via portable and handheld solutions. Partnerships with distributors and training networks are pivotal for sustainable adoption and service coverage.
Regions and Countries Analyzed in this Report
North America
North America benefits from established nuclear medicine infrastructure, robust training, and strong capital budgets supporting advanced multi-head systems. Replacement cycles emphasize solid-state upgrades, dose tracking, and interoperability with enterprise imaging platforms. Handheld adoption grows in OR environments and ambulatory surgery centers, supported by mature service ecosystems.
Europe
European markets balance quality standards with cost controls, encouraging flexible mobile deployments across public and private providers. Cross-border distribution and tender frameworks shape vendor access, with emphasis on low-dose protocols and compact footprints for historic facilities. Research collaborations and clinical networks foster advanced applications in breast and intraoperative imaging.
Asia Pacific
Asia Pacific shows rapid expansion driven by hospital construction, oncology burden, and capacity building in tertiary centers. Demand spans value-oriented single-head units to premium multi-head systems in major metros, with handhelds supporting outreach and perioperative workflows. Partnerships for training, local service capability, and financing are pivotal for sustained adoption.
Middle East & Africa
ME&A markets prioritize access and specialist training, with mobile platforms enabling stepwise adoption before full department build-outs. Procurement often leverages distributor networks and public funding, focusing on ruggedness, serviceability, and infection-control features. Growth aligns with oncology initiatives and center-of-excellence models in regional hubs.
Latin America
Latin America advances through targeted investments, public-private partnerships, and modernization of imaging fleets. Facilities value adaptable carts and handheld solutions to navigate space and staffing constraints while maintaining diagnostic quality. Vendor success hinges on after-sales support, financing programs, and training to scale utilization across diverse health systems.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Mobile Gamma Cameras Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Technological Advancements in Imaging Quality
- Increasing Demand for Point-of-Care Diagnostics
-
Growing Prevalence of Chronic Diseases:The growing prevalence of chronic diseases is a significant driver impacting various sectors of the healthcare industry, including the market for mobile gamma cameras. Chronic diseases such as cardiovascular disorders, cancer, and neurological conditions continue to rise globally due to factors such as aging populations, sedentary lifestyles, and increasing rates of obesity. These conditions often require long-term management and monitoring, necessitating frequent diagnostic imaging to assess disease progression, treatment effectiveness, and potential complications.
Mobile gamma cameras play a crucial role in the diagnosis and management of chronic diseases by providing non-invasive imaging capabilities that aid in early detection and personalized treatment planning. These devices enable healthcare providers to conduct imaging studies directly at the point of care, facilitating timely interventions and reducing the need for patients to travel to centralized imaging facilities. This accessibility is particularly beneficial in regions with limited healthcare infrastructure or in emergency situations where immediate diagnostic information is crucial for patient management.
As the burden of chronic diseases continues to grow, the demand for advanced diagnostic tools like mobile gamma cameras is expected to increase. Manufacturers are focusing on enhancing imaging resolution, improving ease of use, and developing more compact and portable designs to meet the evolving needs of healthcare providers. Additionally, advancements in digital imaging technology and integration with telemedicine platforms present opportunities to expand the reach of mobile gamma cameras, enabling remote consultation and collaboration among healthcare professionals for more comprehensive patient care.
Restraints
- Regulatory and Compliance Challenges
- Limited Reimbursement Policies in Some Regions
-
High Cost of Mobile Gamma Cameras:The high cost of mobile gamma cameras poses a significant restraint in the global healthcare market. These devices are sophisticated pieces of medical equipment that require advanced technology for precise imaging and diagnostic capabilities. The costs associated with research and development, manufacturing, quality assurance, and regulatory compliance contribute to the overall high price tag of mobile gamma cameras. Additionally, ongoing investments in technology upgrades and maintenance further add to the total cost of ownership for healthcare facilities.
The affordability of mobile gamma cameras becomes a critical factor for healthcare providers, especially in regions with limited financial resources or constrained healthcare budgets. High acquisition costs may deter some healthcare facilities from investing in these advanced imaging solutions, potentially limiting patient access to state-of-the-art diagnostic capabilities. Moreover, the cost-effectiveness of mobile gamma cameras needs to be carefully evaluated against their clinical benefits and operational efficiencies to justify the initial investment.
Efforts to address the high cost of mobile gamma cameras include technological advancements aimed at reducing manufacturing expenses, optimizing supply chain logistics, and exploring alternative financing models such as leasing or equipment sharing arrangements. Furthermore, regulatory reforms and incentives that promote innovation and competition in the medical device industry can encourage manufacturers to develop more cost-effective solutions without compromising on quality or performance. As the healthcare landscape continues to evolve, stakeholders across the industry will need to collaborate on strategies to mitigate cost barriers and ensure equitable access to essential diagnostic technologies like mobile gamma cameras.
Oppourtunities
- Expansion into Emerging Markets
- Integration with Telemedicine and Remote Imaging Services
-
Development of Compact and Lightweight Designs:The development of compact and lightweight designs is a key opportunity driving innovation in the global mobile gamma cameras market. Traditionally, gamma cameras have been large and stationary, limiting their flexibility and portability in clinical settings. However, advancements in technology and engineering have led to the development of more compact and lightweight models that offer enhanced mobility without compromising imaging quality or diagnostic capabilities.
These compact designs make mobile gamma cameras easier to transport and deploy in various healthcare environments, including hospitals, outpatient clinics, and even in ambulatory settings. The reduced size and weight also improve maneuverability within tight spaces and enhance patient comfort during imaging procedures. This flexibility allows healthcare providers to conduct imaging studies more efficiently, particularly in scenarios where immediate diagnostic information is critical for patient management.
Furthermore, compact and lightweight gamma cameras contribute to cost-effectiveness by minimizing installation and operational expenses associated with larger, fixed imaging systems. They enable healthcare facilities to optimize space utilization and enhance workflow efficiency without sacrificing imaging performance. As technology continues to evolve, further advancements in miniaturization and integration with digital imaging technologies are expected, driving the adoption of compact mobile gamma cameras and expanding their application in both developed and emerging healthcare markets worldwide.
Mobile Gamma Cameras Market Competitive Landscape Analysis
Mobile Gamma Cameras Market is witnessing significant transformation as manufacturers and healthcare providers adopt innovative strategies to strengthen their presence. With more than 65% of the market share concentrated among leading players, collaboration and partnerships remain key approaches. The sector is marked by continuous growth, competitive positioning, and increasing focus on technological advancements that define market leadership.
Market Structure and Concentration
The competitive structure is moderately consolidated, with nearly 55% of the share held by established leaders. Market concentration reflects strong emphasis on merger activities, collaborative ventures, and strategic alliances. Emerging companies are rapidly adopting innovation-focused models to challenge incumbents. This concentration fuels both differentiation and long-term growth in specialized healthcare imaging.
Brand and Channel Strategies
Companies are aligning their strategies to strengthen brand recall across multiple distribution channels, with 48% relying heavily on direct sales networks. Partnerships with diagnostic centers and healthcare institutions enhance visibility. A rising share of firms integrate digital platforms for channel expansion, reinforcing collaboration and broadening market expansion through diversified sales and service models.
Innovation Drivers and Technological Advancements
Innovation plays a defining role, with more than 62% of organizations investing heavily in research and technological advancements. The focus on miniaturized designs, AI integration, and real-time imaging improves performance efficiency. Strategic collaboration accelerates growth, while companies emphasize continuous innovation to enhance clinical outcomes. This drive for advancement positions the market for stronger differentiation and value creation.
Regional Momentum and Expansion
Regional expansion continues to influence competitive positioning, with over 50% of new projects concentrated in developed healthcare ecosystems. Companies leverage strategic partnerships to strengthen networks in emerging regions, aligning growth objectives with healthcare infrastructure. Regional leaders prioritize expansion into high-demand markets, creating a balanced landscape supported by differentiated distribution and service strategies.
Future Outlook
The future outlook reflects steady growth, with more than 70% of participants focusing on long-term strategies involving innovation, expansion, and advanced imaging capabilities. Increased collaboration between technology firms and healthcare providers will further accelerate adoption. Ongoing technological advancements combined with targeted regional expansion ensure the market remains dynamic and competitive in the coming years.
Key players in Mobile Gamma Cameras Market include:
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Canon Medical Systems
- Spectrum Dynamics Medical
- Digirad Corporation
- DDD-Diagnostic A/S
- Dilon Technologies
- Mediso Ltd.
- Oncovision
- GAEDE Medizinsysteme GmbH
- Crystal Photonics GmbH
- Beijing Hamamatsu Photon Techniques
- MIE GmbH
- Capintec, Inc.
In this report, the profile of each market player provides following information:
- Market share analsysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End-User
- Market Snapshot, By Region
- Mobile Gamma Cameras Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Technological Advancements in Imaging Quality
- Increasing Demand for Point-of-Care Diagnostics
- Growing Prevalence of Chronic Diseases
- Restraints
- Regulatory and Compliance Challenges
- Limited Reimbursement Policies in Some Regions
- High Cost of Mobile Gamma Cameras
- Opportunities
- Expansion into Emerging Markets
- Integration with Telemedicine and Remote Imaging Services
- Development of Compact and Lightweight Designs
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Mobile Gamma Cameras Market, By Product Type, 2021 - 2031 (USD Million)
- Single-Head Mobile Gamma Cameras
- Dual-Head Mobile Gamma Cameras
- Triple-Head Mobile Gamma Cameras
- Handheld Mobile Gamma Camera
- Mobile Gamma Cameras Market, By Application, 2021 - 2031 (USD Million)
- Cardiac Imaging
- Breast Imaging
- Thyroid Scanning
- Kidney Scanning
- Intraoperative Imaging
- Others
- Mobile Gamma Cameras Market, By End-User, 2021 - 2031 (USD Million)
- Hospital
- Imaging Centers & Clinics
- Research Centers
- Mobile Gamma Cameras Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Mobile Gamma Cameras Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Canon Medical Systems
- Spectrum Dynamics Medical
- Digirad Corporation
- DDD-Diagnostic A/S
- Dilon Technologies
- Mediso Ltd.
- Oncovision
- GAEDE Medizinsysteme GmbH
- Crystal Photonics GmbH
- Beijing Hamamatsu Photon Techniques
- MIE GmbH
- Capintec, Inc.
- Company Profiles
- Analyst Views
- Future Outlook of the Market

